StonvexLoading…
StonvexStonvexStonvexCore line items from PCT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $8.36M | $0.00 | $0.00 |
Operating Income | $-181.44M | $-145.38M | $-113.90M |
Net Income | $-182.56M | $-289.14M | $-101.72M |
EPS (Diluted) | $-1.21 | $-1.75 | $-0.63 |
Total Assets | $922.67M | $798.38M | $1.04B |
Total Liabilities | $572.08M | $617.94M | $619.14M |
Cash & Equivalents | $156.69M | $15.68M | $73.41M |
Free Cash Flow OCF − CapEx | $-183.59M | $-200.41M | $-248.81M |
Shares Outstanding | 180.28M | 173.57M | 164.28M |